Drug Discovery World

MARCH 7, 2023

For International Women’s Day, DDW’s Diana Spencer celebrates some of the women in leadership making an impact on the drug discovery and life sciences sector. The life sciences sector has traditionally outperformed others when it comes to attracting women to its workforce. Anti-ageing science therefore has huge value.

International 246

International Science Pharmaceuticals DNA 246

Drug Discovery World

FEBRUARY 28, 2023

Dr Asma Patel , Vice President of Integrated Services for Early Development at Quotient Sciences, reflects on the biggest barriers to rare disease drug development and how companies can overcome these. The post What is the biggest barrier to rare disease drug development?

Drug Development 130

Drug Development Disease Drugs Production 130

Perficient: Drug Development

JANUARY 31, 2024

Computer Science, Data Science, Journey Science. Computer Science: The Here and Now In the beginning, Computer Science was abstract. This would let humans focus on functions that mattered more, like advancing science or the arts. Next, AI and Machine-Learning became critical capabilities for the Enterprise.

Science 98

Science Production 98

Drug Discovery World

FEBRUARY 16, 2024

Another factor he mentioned is that drug development is focused on an efficacy versus effectiveness problem, which Rombotis also mentioned. He said: “We move from asking whether a drug will be effective in a population of patients, to questions around whether this drug or combination of drugs will be effective for the patient”.

Science 130

Science Research Vaccine Production 130

Drug Discovery World

JULY 4, 2023

Vesalius Biocapital, a life sciences venture capital investor, has closed its fourth fund, Vesalius Biocapital IV, securing over €95 million of commitments. The company plans to invest in first and best-in-class European life science companies in drug development and digital health.

Science 130

Science Drug Development Production Drugs 130

Drug Discovery World

OCTOBER 31, 2023

PwC has published a new report on the UK life sciences industry ‘The Life Sciences Future50’, highlighting companies that illustrate world-class science and innovation, including 32 in the therapeutics space. According to the report, the life science industry represents a £43.4 ($52.7)

Science 130

Science Drugs Research Drug Development 130

Drug Discovery World

MARCH 16, 2023

There was some good news for the UK life sciences sector in the government’s Spring Budget, but did it go far enough? It will target UK taxpayer support to enable life science entrepreneurs to crowd in further private investment allowing them to grow and accelerate innovation in the UK.”

Science 243

Science Government Regulations Pharmaceuticals 243

Drug Discovery World

OCTOBER 10, 2023

The grant is intended to support the entire trajectory of drug development – from the proof-of-concept studies through to the IND-enabling studies required for a clinical trial and the Phase I/II clinical trial for both diseases. This grant supports a complete bench-to-bedside arc,” said Dr Berent, Chief Science Officer at FAST. “It

Drug Development 130

Drug Development Clinical Trials Engineering Drugs 130

Drug Discovery World

JANUARY 30, 2024

Aurora Microplates has great respect for the demands of modern discovery science and its ever-evolving search for more sensitive and subtle clues to understanding cause and effect. The post High-performance microplates for discovery sciences appeared first on Drug Discovery World (DDW).

Science 130

Science Assay Development Production Drugs 130

Drug Discovery World

MARCH 2, 2023

AI is revolutionising clinical trials and drug developments just as it is transforming other sectors, but in order for AI to make progress in rare diseases, the UK needs further investment to increase uptake and use. Changing the business model behind drug development is the first step. This needs to change.

Drug Development 130

Drug Development Disease Clinical Trials Drugs 130

Drug Discovery World

OCTOBER 9, 2023

DS: A paper in Science showed this month how mitochondrial function in the organs is impaired by Covid-19, potentially after the infection has cleared, causing long Covid. Hinshaw also played a key role on the Global Oncology Executive Committee, including leading key strategic programmes to maximise the portfolio and pipeline development.

Drug Development 147

Drug Development Clinical Trials Virus Molecular Biology 147

Drug Discovery World

NOVEMBER 23, 2022

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has launched a new Community of Experts (CoE) with the aim of harnessing real-world data (RWD) from social media. As such, companies are increasingly using social media to produce Real-World Evidence (RWE).

Drug Development 130

Drug Development Drugs Government Science 130

Drug Discovery World

MARCH 6, 2023

The post Institiute gives a boost to five new life science start-ups appeared first on Drug Discovery World (DDW). In total, BII’s start-ups have raised over €333 million in external funding from both local and international investors.

Science 130

Science RNA Disease International 130

Drug Discovery World

JULY 19, 2023

The tide has been turning in the worlds of diagnostics and drug development. Bioinformatics and genetic sequencing are starting to be placed front and centre of public research programmes as scientists from around the world recognise the substantial benefits of knowledge sharing and resource pooling when it comes to genetic science.

Science 130

Science Bioinformatics Pharma Companies Disease 130

Alta Sciences

DECEMBER 29, 2023

Life Science Review: Altasciences—Eliminating Operational Silos to Accelerate and Streamline Early-Phase Drug Development aasimakopoulos Fri, 12/29/2023 - 14:48 Category News Weight 5

Drug Development 40

Drug Development Science Drugs 40

Drug Discovery World

AUGUST 5, 2022

Ian Hollingsworth, Associate Director of product development at Boyds, the global drug development consultancy, explains the benefits to the drug development lifecycle of building strong partnerships with external consultants, and when and how to get the best from them. Why sponsors use external consultants.

Drug Development 130

Drug Development Drugs Pharma Companies International 130

Drug Discovery World

FEBRUARY 27, 2023

For founders planning to launch their start-ups, specifically drug developers, there needs to be sound, foundational science with promising data that will enable you to push further down the drug discovery pipeline. DS: You were recognised in the 2023 Forbes’ 30 under 30 for Science.

RNA 130

RNA Science Small Molecule Engineering 130

Broad Institute

DECEMBER 18, 2023

Brain disorders are difficult to study and many drug candidates have failed in clinical trials, causing pharmaceutical companies to reduce their investments or even exit the field entirely. But a new path for bringing treatments to patients is starting to emerge.

Drug Development 130

Drug Development Clinical Trials Drugs Disease 130

Fierce BioTech

APRIL 4, 2024

Discover how leading organizations leverage AI to revolutionize operations and expedite drug development, ensuring faster access to life-saving treatments. Gain insights into successful case studies and strategies for leveraging AI in life science innovation. Click here to login. Listing Image Appian-LogoListing-9142023.png

Science 52

Science Compliance Drug Development Treatment 52

Drug Discovery World

JANUARY 26, 2023

Kadans Science Partner and Canary Wharf Group (CWG), London, are developing an innovation facility providing access to fully fitted laboratories and space for developing life science companies , following the announcement of a joint venture to establish a new UK Life Sciences cluster at Canary Wharf.

Science 130

Science Laboratories International Marketing 130

Alta Sciences

AUGUST 29, 2023

Embarking on a Career in Drug Development nbartlett Tue, 08/29/2023 - 14:38 Getting to the Heart of Science with Amber malloy Amber Malloy, Altasciences At the heart of science are stories—stories of courage, challenges, successes, lessons, and people. They remind us of the immense benefits of drug development.

Drug Development 52

Drug Development Analytical Chemistry Drugs Science 52

Alta Sciences

APRIL 17, 2024

Five Promising Treatment Areas in Early-Phase Drug Development in 2024 aasimakopoulos Wed, 04/17/2024 - 15:52 Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues.

Drug Development 52

Drug Development Treatment FDA Approval Therapies 52

Drug Discovery World

DECEMBER 19, 2022

Here, she unpacks some of the areas in which social media plays a role in the drug discovery world. . For example, insights into the benefits of a therapy, previously unreported side effects, or new symptoms, which can be used to inform drug development and improve outcomes for future patients. Data collection .

Science 130

Science FDA FDA Approval Vaccine 130

EG Life Sciences

FEBRUARY 15, 2023

The year 2022 reflected a transformative path for the drug development industry. Every year, the FDA’s Center for Drug Evaluation and Research (CDER) clarifies to drug developers required study design elements, as well as other data needed on the drug application to support a full and comprehensive assessment.

Drug Development 52

Drug Development FDA Approval Virus Drugs 52

Drug Discovery World

SEPTEMBER 5, 2022

Throughout the continuum of drug development, from target discovery to patient selection, machine learning approaches are being adopted to reliably mine vast amounts of data and make predictions with higher accuracy Anita Ramanathan discusses how machine learning is currently used across different stages of cancer research. .

Drug Development 130

Drug Development Protein Expression Drugs Therapies 130

Drug Target Review

JANUARY 8, 2024

We are at the forefront of drug development in an area of research called cellular rejuvenation, which is an approach that has the potential to address many diseases of ageing by restoring aged and injured cells to a more youthful and resilient state.

Science 145

Science FDA Approval Disease DNA 145

LifeSciVC

FEBRUARY 27, 2024

By Ivana Magovčević-Liebisch, CEO of Vigil Neuroscience, as part of the From The Trenches feature of LifeSciVC Patients and their care partners are at the center of our work in the life sciences industry – but at what point during the drug development process should companies start to engage these key stakeholders?

Drug Development 61

Drug Development Disease Drugs Treatment 61

Alta Sciences

OCTOBER 30, 2023

Top 10 Life Science Resources pmjackson Mon, 10/30/2023 - 16:16 There’s a lot of life science content out there, which is why we’ve curated a selection of our expert insights, tips, case studies, and scientific and regulatory information for you. Catch up on what you may have missed below! Watch the video. Listen here.

Science 52

Science Clinical Trials Pharmacokinetics Pharmacy 52

Conversations in Drug Development Trends

AUGUST 10, 2023

With so many exciting developments in the last few years, it’s critical for the psychedelic community to come together to reflect on our progress, share the latest discoveries, and discuss the future of psychedelic research. The post 3 Key Takeaways from Psychedelic Science 2023 appeared first on Worldwide Clinical Trials.

Science 98

Science Clinical Trials Trials Clinical Research 98

Drug Target Review

FEBRUARY 15, 2024

2023 May 12; Available from: [link] National Academies of Sciences, Engineering, and Medicine. Proceedings of the National Academy of Sciences. The New York Times. Biodefense in the Age of Synthetic Biology. Washington, D.C.: National Academies Press; 2018. Available from: [link] Bioterrorism [Internet]. 2017 Apr 10;114(16):4031–3.

Drug Development 122

Drug Development Virus Vaccine Government 122

LifeSciVC

JANUARY 3, 2024

This is an exciting development both for HotSpot and for the field – not only has the CBM complex been successfully targeted in vitro and in vivo for the first time, but we believe we now have a roadmap for drugging other signaling assemblies relevant to disease.

Drug Development 90

Drug Development Drugs Small Molecule Disease 90

Perficient: Drug Development

MARCH 14, 2024

So how can healthcare and life sciences organizations capitalize on this opportunity? Lunch and Networking: Dine and connect with healthcare and life sciences industry peers who share your passion for digital excellence before heading off for afternoon sessions at Adobe Summit. . What to Expect 11:30 A.M.

Science 52

Science Pharmacy Marketing Production 52

Alta Sciences

JULY 28, 2023

Listen to the audiobook >>> ​​​ Issue 33 — CNS Drug Development: Integrated Solutions Lessen Complexity Hear about the complexities of CNS drug development programs and how an integrated CRO/CDMO can help move your molecule seamlessly from one phase to the next. Listen to the audiobook >>> Image Social Media Promo-01.jpg

Science 52

Science Clinical Research Clinical Trials Drug Development 52

H1 Blog

OCTOBER 30, 2023

The application of AI in the life sciences sector has the potential to revolutionize many aspects of research, development, and patient care. Here are 4 predictions for how life sciences companies might be using AI by then. Drug Repurposing AI can analyze existing drugs and their effects to find new therapeutic applications.

Science 59

Science Clinical Trials Engineering Trials 59

FDA Law Blog: Biosimilars

JUNE 27, 2023

James was only one of five life sciences attorneys selected and the only food and drug lawyer to make the list. Amongst his accomplishments, Law360 considered the role James has played in leveraging little-used pathways to FDA approval for often first-ever drugs to treat rare diseases (e.g., Valentine , as a 2023 Rising Star.

Science 81

Science FDA Approval FDA Drug Development 81

Perficient: Drug Development

OCTOBER 17, 2023

The term “business transformation” in healthcare and life sciences sig nifies more than just an industry trend. In the context of healthcare and life sciences, changes are driven by a combination of evolving patient and member needs, increased market competition, technological advancements, and shifting regulatory landscapes.

Science 52

Science Marketing 52

Perficient: Drug Development

JANUARY 16, 2024

I’ve spent essentially my entire career in the medical device and life science space, and it didn’t start the way you would think. With all this in mind, here are three ways medical device and life science companies can leverage Adobe Commerce to build solutions that help everyone within the healthcare lifecycle.

Science 52

Science Nurses Production Pharmacy 52